1
|
Gui LG, Shi M, Li J. Cone beam computed tomography and image registration based on target area for stereotactic body radiation therapy of lung cancer. JOURNAL OF RADIATION RESEARCH AND APPLIED SCIENCES 2021. [DOI: 10.1080/16878507.2021.1981754] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Affiliation(s)
- Long-Gang Gui
- Radiotherapy Center, Northern Jiangsu People’s Hospital, Yangzhou, China
| | - Miao Shi
- Radiotherapy Center, Northern Jiangsu People’s Hospital, Yangzhou, China
| | - Jun Li
- Radiotherapy Center, Northern Jiangsu People’s Hospital, Yangzhou, China
| |
Collapse
|
2
|
Dose volume histogram metrics and tumour control probability modelling in locally advanced non-small-cell lung cancer: average intensity dataset versus individual four-dimensional CT phases. JOURNAL OF RADIOTHERAPY IN PRACTICE 2020. [DOI: 10.1017/s146039692000076x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Abstract
AbstractAim:This work compares dose-volume constraints (DVCs) and tumour control predictions based on the average intensity projection (AVIP) to those on each phase of the four-dimensional computed tomography.Materials and methods:In this prospective study plans generated on an AVIP for nine patients with locally advanced non-small-cell lung cancer were recalculated on each phase. Dose-volume histogram (DVH) metrics extracted and tumour control probabilities (TCP) were calculated. These were evaluated by Bland–Altman analysis and Pearson Correlation.Results:The largest difference between clinical target volume (CTV) on the individual phases and the internal CTV (iCTV) on the AVIP was seen for the smallest volume. For the planning target volume, the mean of each metric across all phases is well represented by the AVIP value. For most patients, TCPs from individual phases are representative of that on the AVIP. Organ at risk metrics from the AVIP are similar to those seen across all phases.Findings:Utilising traditional DVH metrics on an AVIP is generally valid, however, additional investigation may be required for small target volumes in combination with large motion as the differences between the values on the AVIP and any given phase may be significant.
Collapse
|
3
|
Keiper TD, Tai A, Chen X, Paulson E, Lathuilière F, Bériault S, Hébert F, Cooper DT, Lachaine M, Li XA. Feasibility of real‐time motion tracking using cine MRI during MR‐guided radiation therapy for abdominal targets. Med Phys 2020; 47:3554-3566. [DOI: 10.1002/mp.14230] [Citation(s) in RCA: 20] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/25/2019] [Revised: 03/31/2020] [Accepted: 04/30/2020] [Indexed: 12/25/2022] Open
Affiliation(s)
- Timothy D. Keiper
- Department of Radiation Oncology Medical College of Wisconsin 8701 Watertown Plank Rd Milwaukee WI 53226 USA
| | - An Tai
- Department of Radiation Oncology Medical College of Wisconsin 8701 Watertown Plank Rd Milwaukee WI 53226 USA
| | - Xinfeng Chen
- Department of Radiation Oncology Medical College of Wisconsin 8701 Watertown Plank Rd Milwaukee WI 53226 USA
| | - Eric Paulson
- Department of Radiation Oncology Medical College of Wisconsin 8701 Watertown Plank Rd Milwaukee WI 53226 USA
| | | | | | - François Hébert
- Elekta 2050 Rue de Bleury Suite 200 Montréal QC H3A 2J5 Canada
| | - David T. Cooper
- Elekta 2050 Rue de Bleury Suite 200 Montréal QC H3A 2J5 Canada
| | - Martin Lachaine
- Elekta 2050 Rue de Bleury Suite 200 Montréal QC H3A 2J5 Canada
| | - X. Allen Li
- Department of Radiation Oncology Medical College of Wisconsin 8701 Watertown Plank Rd Milwaukee WI 53226 USA
| |
Collapse
|
4
|
Lei Y, Fu Y, Wang T, Liu Y, Patel P, Curran WJ, Liu T, Yang X. 4D-CT deformable image registration using multiscale unsupervised deep learning. Phys Med Biol 2020; 65:085003. [PMID: 32097902 PMCID: PMC7775640 DOI: 10.1088/1361-6560/ab79c4] [Citation(s) in RCA: 36] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
Abstract
Deformable image registration (DIR) of 4D-CT images is important in multiple radiation therapy applications including motion tracking of soft tissue or fiducial markers, target definition, image fusion, dose accumulation and treatment response evaluations. It is very challenging to accurately and quickly register 4D-CT abdominal images due to its large appearance variances and bulky sizes. In this study, we proposed an accurate and fast multi-scale DIR network (MS-DIRNet) for abdominal 4D-CT registration. MS-DIRNet consists of a global network (GlobalNet) and local network (LocalNet). GlobalNet was trained using down-sampled whole image volumes while LocalNet was trained using sampled image patches. MS-DIRNet consists of a generator and a discriminator. The generator was trained to directly predict a deformation vector field (DVF) based on the moving and target images. The generator was implemented using convolutional neural networks with multiple attention gates. The discriminator was trained to differentiate the deformed images from the target images to provide additional DVF regularization. The loss function of MS-DIRNet includes three parts which are image similarity loss, adversarial loss and DVF regularization loss. The MS-DIRNet was trained in a completely unsupervised manner meaning that ground truth DVFs are not needed. Different from traditional DIRs that calculate DVF iteratively, MS-DIRNet is able to calculate the final DVF in a single forward prediction which could significantly expedite the DIR process. The MS-DIRNet was trained and tested on 25 patients' 4D-CT datasets using five-fold cross validation. For registration accuracy evaluation, target registration errors (TREs) of MS-DIRNet were compared to clinically used software. Our results showed that the MS-DIRNet with an average TRE of 1.2 ± 0.8 mm outperformed the commercial software with an average TRE of 2.5 ± 0.8 mm in 4D-CT abdominal DIR, demonstrating the superior performance of our method in fiducial marker tracking and overall soft tissue alignment.
Collapse
Affiliation(s)
- Yang Lei
- Department of Radiation Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, 30322
| | | | | | | | | | | | | | | |
Collapse
|
5
|
Gensanne D, Hadj Henni A, Lauzin Y, Clarisse P, Thureau S. [Inter- and intrafraction imaging during stereotactic body radiation therapy: Which solutions for which tumours?]. Cancer Radiother 2019; 23:891-895. [PMID: 31615729 DOI: 10.1016/j.canrad.2019.09.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/15/2019] [Revised: 08/29/2019] [Accepted: 09/02/2019] [Indexed: 10/25/2022]
Abstract
Due to high dose gradients, stereotactic body radiation therapy requires high precision in the location of the tumour. Uncertainties in the positioning can introduce serious damage on organs at risk and consequently can reduce tumour local control. A better tumour location can be achieved by controlling its position with an efficient inter and intrafraction imaging procedure. The various imaging techniques available on treatment systems are presented and performances are discussed. Finally, propositions are given in terms of imaging system according to the location treated by stereotactic body radiation therapy.
Collapse
Affiliation(s)
- D Gensanne
- Centre Henri-Becquerel, département de radiothérapie et de physique médicale, rue d'Amiens, CS 11516, 76038 Rouen cedex 1, France.
| | - A Hadj Henni
- Centre Henri-Becquerel, département de radiothérapie et de physique médicale, rue d'Amiens, CS 11516, 76038 Rouen cedex 1, France
| | - Y Lauzin
- Centre Henri-Becquerel, département de radiothérapie et de physique médicale, rue d'Amiens, CS 11516, 76038 Rouen cedex 1, France
| | - P Clarisse
- Centre Henri-Becquerel, département de radiothérapie et de physique médicale, rue d'Amiens, CS 11516, 76038 Rouen cedex 1, France
| | - S Thureau
- Centre Henri-Becquerel, département de radiothérapie et de physique médicale, rue d'Amiens, CS 11516, 76038 Rouen cedex 1, France; Quantif-Litis EA 4108, université de Rouen, 76000 Rouen, France
| |
Collapse
|
6
|
Ahmed KA, Torres-Roca JF. Stereotactic Body Radiotherapy in the Management of Oligometastatic Disease. Cancer Control 2016; 23:21-9. [PMID: 27009453 DOI: 10.1177/107327481602300105] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022] Open
Abstract
BACKGROUND The treatment of oligometastatic disease has become common as imaging techniques have advanced and the management of systemic disease has improved. Use of highly targeted, hypofractionated regimens of stereotactic body radiotherapy (SBRT) is now a primary management option for patients with oligometastatic disease. METHODS The properties of SBRT are summarized and the results of retrospective and prospective studies of SBRT use in the management of oligometastases are reviewed. Future directions of SBRT, including optimizing dose and fractionation schedules, are also discussed. RESULTS SBRT can deliver highly conformal, dosed radiation treatments for ablative tumors in a few treatment sessions. Phase 1/2 trials and retrospective institutional results support use of SBRT as a treatment option for oligometastatic disease metastasized to the lung, liver, and spine, and SBRT offers adequate toxicity profiles with good rates of local control. Future directions will involve optimizing dose and fractionation schedules for select histologies to improve rates of local control while limiting toxicity to normal structures. CONCLUSIONS SBRT offers an excellent management option for patients with oligometastases. However, additional research is still needed to optimize dose and fractionation schedules.
Collapse
|
7
|
Kim SK, Wu CC, Horowitz DP. Stereotactic body radiotherapy for the pancreas: a critical review for the medical oncologist. J Gastrointest Oncol 2016; 7:479-86. [PMID: 27284482 DOI: 10.21037/jgo.2015.10.01] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/17/2022] Open
Abstract
With recent advances in imaging modalities and radiation therapy, stereotactic body radiotherapy (SBRT) has allowed for the delivery of high doses of radiation with accuracy and precision. As such, SBRT has generated favorable results in the treatment of several cancers. Although the role of radiation has been controversial for the treatment of pancreatic ductal adenocarcinoma (PDAC) due to rather lackluster results in clinical trials, SBRT may offer improved outcomes, enhance the quality of life, and aid in palliative care settings for PDAC patients. This review delineates the role of SBRT in the treatment of PDAC, presents the defining principles of radiation biology and the radiation oncology work flow, and discusses the prospects of new treatment regimens involving tumor immunology and radiation therapy.
Collapse
Affiliation(s)
- Samuel K Kim
- Department of Radiation Oncology, New York Presbyterian Hospital, Columbia University Medical Center, New York, NY 10032, USA
| | - Cheng-Chia Wu
- Department of Radiation Oncology, New York Presbyterian Hospital, Columbia University Medical Center, New York, NY 10032, USA
| | - David P Horowitz
- Department of Radiation Oncology, New York Presbyterian Hospital, Columbia University Medical Center, New York, NY 10032, USA
| |
Collapse
|
8
|
Rong Y, Bazan JG, Sekhon A, Haglund K, Xu-Welliver M, Williams T. Minimal Inter-Fractional Fiducial Migration during Image-Guided Lung Stereotactic Body Radiotherapy Using SuperLock Nitinol Coil Fiducial Markers. PLoS One 2015; 10:e0131945. [PMID: 26158847 PMCID: PMC4497733 DOI: 10.1371/journal.pone.0131945] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/13/2015] [Accepted: 06/08/2015] [Indexed: 12/26/2022] Open
Abstract
Objectives Stereotactic body radiotherapy (SBRT) is being increasingly used for the treatment of patients with lung cancer or lung metastasis who are medically unfit to undergo resection. In order to improve accuracy and confidence in targeting tumors, many centers rely on fiducial implantation. We evaluated the migration of a novel fiducial marker specifically designed for lung tissue implanted via electromagnetic navigation bronchoscopy (ENB). Methods We retrospectively quantified the individual and group migrations of SuperLock nitinol coil fiducials for 15 patients receiving lung stereotactic body radiotherapy (SBRT), in order to evaluate the reliability of using these fiducials as a target surrogate for cases where tumors cannot be clearly delineated on cone beam CTs (CBCTs). For each fraction, we compared the individual and group migrations of the fiducials between the planning CT and the acquired CBCT. The group migration was defined as the distance between the centroids of the fiducial group and GTV. Results A total of 16 lung targets were included in our study for these 15 patients (one patient with two targets). Of 55 fiducials placed, we observed a 100% retention rate. The mean individual migration was 1.87 mm (range, 0.63–5.25 mm) with a standard deviation of 1.26 mm. The mean group migration was 1.94 mm (range, 0.03–6.19 mm) with a standard deviation of 1.45 mm. Overall, there was minimal change in the relative locations of the markers with respect to each other, as well as to the target. Conclusions We found that the SuperLock nitinol coil fiducial marker positions are stable throughout the radiation treatment, and can be used as a reliable surrogate to target, and to avoid geometric misses during gated treatments.
Collapse
Affiliation(s)
- Yi Rong
- Department of Radiation Oncology, University of California Davis Comprehensive Cancer Center, Sacramento, CA, 95817, United States of America
- * E-mail: (YR); (TW)
| | - Jose G. Bazan
- Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus, OH, 43210, United States of America
| | - Ashley Sekhon
- Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus, OH, 43210, United States of America
| | - Karl Haglund
- Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus, OH, 43210, United States of America
| | - Meng Xu-Welliver
- Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus, OH, 43210, United States of America
| | - Terence Williams
- Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus, OH, 43210, United States of America
- * E-mail: (YR); (TW)
| |
Collapse
|
9
|
Moningi S, Marciscano AE, Rosati LM, Ng SK, Teboh Forbang R, Jackson J, Chang DT, Koong AC, Herman JM. Stereotactic body radiation therapy in pancreatic cancer: the new frontier. Expert Rev Anticancer Ther 2014; 14:1461-75. [PMID: 25183386 DOI: 10.1586/14737140.2014.952286] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
Pancreatic cancer (PCA) remains a disease with a poor prognosis. The majority of PCA patients are unable to undergo surgical resection, which is the only potentially curative option at this time. A combination of chemotherapy and chemoradiation (CRT) are standard options for patients with locally advanced, unresectable disease, however, local control and patient outcomes remains poor. Stereotactic body radiation therapy (SBRT) is an emerging treatment option for PCA. SBRT delivers potentially ablative doses to the pancreatic tumor plus a small margin over a short period of time. Early studies with single-fraction SBRT demonstrated excellent tumor control with high rates of toxicity. The implementation of SBRT (3-5 doses) has demonstrated promising outcomes with favorable tumor control and toxicity rates. Herein we discuss the evolving role of SBRT in PCA treatment.
Collapse
Affiliation(s)
- Shalini Moningi
- Department of Radiation Oncology and Molecular Radiation Sciences, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, 401 N. Broadway, Weinberg Suite 1440, Baltimore, MD 21231, USA
| | | | | | | | | | | | | | | | | |
Collapse
|
10
|
Fan Q, Nanduri A, Yang J, Yamamoto T, Loo B, Graves E, Zhu L, Mazin S. Toward a planning scheme for emission guided radiation therapy (EGRT): FDG based tumor tracking in a metastatic breast cancer patient. Med Phys 2014; 40:081708. [PMID: 23927305 DOI: 10.1118/1.4812427] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022] Open
Abstract
PURPOSE Emission guided radiation therapy (EGRT) is a new modality that uses PET emissions in real-time for direct tumor tracking during radiation delivery. Radiation beamlets are delivered along positron emission tomography (PET) lines of response (LORs) by a fast rotating ring therapy unit consisting of a linear accelerator (Linac) and PET detectors. The feasibility of tumor tracking and a primitive modulation method to compensate for attenuation have been demonstrated using a 4D digital phantom in our prior work. However, the essential capability of achieving dose modulation as in conventional intensity modulated radiation therapy (IMRT) treatments remains absent. In this work, the authors develop a planning scheme for EGRT to accomplish sophisticated intensity modulation based on an IMRT plan while preserving tumor tracking. METHODS The planning scheme utilizes a precomputed LOR response probability distribution to achieve desired IMRT planning modulation with effects of inhomogeneous attenuation and nonuniform background activity distribution accounted for. Evaluation studies are performed on a 4D digital patient with a simulated lung tumor and a clinical patient who has a moving breast cancer metastasis in the lung. The Linac dose delivery is simulated using a voxel-based Monte Carlo algorithm. The IMRT plan is optimized for a planning target volume (PTV) that encompasses the tumor motion using the MOSEK package and a Pinnacle3™ workstation (Philips Healthcare, Fitchburg, WI) for digital and clinical patients, respectively. To obtain the emission data for both patients, the Geant4 application for tomographic emission (GATE) package and a commercial PET scanner are used. As a comparison, 3D and helical IMRT treatments covering the same PTV based on the same IMRT plan are simulated. RESULTS 3D and helical IMRT treatments show similar dose distribution. In the digital patient case, compared with the 3D IMRT treatment, EGRT achieves a 15.1% relative increase in dose to 95% of the gross tumor volume (GTV) and a 31.8% increase to 50% of the GTV. In the patient case, EGRT yields a 15.2% relative increase in dose to 95% of the GTV and a 20.7% increase to 50% of the GTV. The organs at risk (OARs) doses are kept similar or lower for EGRT in both cases. Tumor tracking is observed in the presence of planning modulation in all EGRT treatments. CONCLUSIONS As compared to conventional IMRT treatments, the proposed EGRT planning scheme allows an escalated target dose while keeping dose to the OARs within the same planning limits. With the capabilities of incorporating planning modulation and accurate tumor tracking, EGRT has the potential to greatly improve targeting in radiation therapy and enable a practical and effective implementation of 4D radiation therapy for planning and delivery.
Collapse
Affiliation(s)
- Qiyong Fan
- Nuclear and Radiological Engineering Program, The George W. Woodruff School of Mechanical Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332, USA
| | | | | | | | | | | | | | | |
Collapse
|
11
|
Yoon K, Kwak J, Cho B, Song S, Lee S, Ahn S, Nam S. Development of New 4D Phantom Model in Respiratory Gated Volumetric Modulated Arc Therapy for Lung SBRT. ACTA ACUST UNITED AC 2014. [DOI: 10.14316/pmp.2014.25.2.100] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Affiliation(s)
- KyoungJun Yoon
- Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Korea
| | - JungWon Kwak
- Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Korea
| | - ByungChul Cho
- Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Korea
| | - SiYeol Song
- Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Korea
| | - SangWook Lee
- Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Korea
| | - SeungDo Ahn
- Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Korea
| | - SangHee Nam
- Department of Biomedical Engineering, Inje University, Kyongnam, Korea
| |
Collapse
|
12
|
Wu J, Betzing C, He TT, Fuss M, D'Souza WD. Dosimetric comparison of patient setup strategies in stereotactic body radiation therapy for lung cancer. Med Phys 2013; 40:051709. [PMID: 23635257 DOI: 10.1118/1.4801926] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
Abstract
PURPOSE In this work, the authors retrospectively compared the accumulated dose over the treatment course for stereotactic body radiation therapy (SBRT) of lung cancer for three patient setup strategies. METHODS Ten patients who underwent lung SBRT were selected for this study. At each fraction, patients were immobilized using a vacuum cushion and were CT scanned. Treatment plans were performed on the simulation CT. The planning target volume (PTV) was created by adding a 5-mm uniform margin to the internal target volume derived from the 4DCT. All plans were normalized such that 99% of the PTV received 60 Gy. The plan parameters were copied onto the daily CT images for dose recalculation under three setup scenarios: skin marker, bony structure, and soft tissue based alignments. The accumulated dose was calculated by summing the dose at each fraction along the trajectory of a voxel over the treatment course through deformable image registration of each CT with the planning CT. The accumulated doses were analyzed for the comparison of setup accuracy. RESULTS The tumor volume receiving 60 Gy was 91.7 ± 17.9%, 74.1 ± 39.1%, and 99.6 ± 1.3% for setup using skin marks, bony structures, and soft tissue, respectively. The isodose line covering 100% of the GTV was 55.5 ± 7.1, 42.1 ± 16.0, and 64.3 ± 7.1 Gy, respectively. The corresponding average biologically effective dose of the tumor was 237.3 ± 29.4, 207.4 ± 61.2, and 258.3 ± 17.7 Gy, respectively. The differences in lung biologically effective dose, mean dose, and V20 between the setup scenarios were insignificant. CONCLUSIONS The authors' results suggest that skin marks and bony structure are insufficient for aligning patients in lung SBRT. Soft tissue based alignment is needed to match the prescribed dose delivered to the tumors.
Collapse
Affiliation(s)
- Jianzhou Wu
- Radiation Oncology, Swedish Cancer Institute, Seattle, Washington 98104, USA.
| | | | | | | | | |
Collapse
|
13
|
Wang L, Chen X, Lin MH, Xue J, Lin T, Fan J, Jin L, Ma CM. Evaluation of the cone beam CT for internal target volume localization in lung stereotactic radiotherapy in comparison with 4D MIP images. Med Phys 2013; 40:111709. [DOI: 10.1118/1.4823785] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022] Open
|
14
|
Wang L, Feigenberg S, Fan J, Jin L, Turaka A, Chen L, Ma CMC. Target repositional accuracy and PTV margin verification using three-dimensional cone-beam computed tomography (CBCT) in stereotactic body radiotherapy (SBRT) of lung cancers. J Appl Clin Med Phys 2012; 13:3708. [PMID: 22402387 PMCID: PMC5716422 DOI: 10.1120/jacmp.v13i2.3708] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/19/2011] [Accepted: 11/15/2011] [Indexed: 01/08/2023] Open
Abstract
The purpose of this study was to assess target repositional accuracy with respect to the bony structures using daily CBCT, and to validate the planning target volume (PTV) margin used in the lung SBRT. All patients underwent 4D CT scanning in preparation for lung SBRT. The internal target volume (ITV) was outlined from the reconstructed 4D data using the maximum‐intensity projection (MIP) algorithm. A 6 mm margin was added to the ITV to create the PTV. Conformal treatment planning was performed on the helical images, to which the MIP images were fused. Prior to each treatment, CBCT was taken after a patient was set up in the treatment position. The CBCT images were fused with the simulation CT based on the bony anatomy, in order to derive setup errors and separate them from the tumor repositional errors. The treating physician then checked and modified the alignment based on target relocalization within the PTV. The shifts determined in such a method were recorded and the subtractions of these shifts with respect to the corresponding setup errors were defined as the target relocalization accuracy. Our study of 36 consecutive patients, treating 38 targets for a total of 153 fractions shows that, after setup error correction, the target repositional accuracy followed a normal distribution with the mean values close to 0 in all directions, and standard deviations of 0.25 cm in A–P, 0.24 cm in Lat, and 0.28 cm in S–I directions, respectively. The probability of having the shifts ≥0.6cm is less than 0.8% in A–P, 0.6% in Lat, and 1.7 % in S‐I directions. For the patient population studied, the target centroid position relative to the bony structures changed minimally from day to day. This demonstrated that the PTV margin that is designed on the MIP image‐based ITV was adequate for lung SBRT. PACS number: 87.53.Ly
Collapse
Affiliation(s)
- Lu Wang
- Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
| | | | | | | | | | | | | |
Collapse
|
15
|
Roland T, Hales R, McNutt T, Wong J, Simari P, Tryggestad E. A method for deriving a 4D-interpolated balanced planning target for mobile tumor radiotherapy. Med Phys 2011; 39:195-205. [DOI: 10.1118/1.3666774] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022] Open
|
16
|
Abstract
Modern radiation oncology relies heavily on emerging technology. In this article, we review recent advances in target delineation as it applies to radiation treatment planning. We focus on the evidence to support methionine positron emission tomography use for target delineation in primary brain tumors, 2-deoxy-2-[(18)F] fluoro-D-glucose positron emission tomography use for target delineation for lung cancer and head and neck cancer, and the use of magnetic resonance imaging sequences for target delineation in prostate cancer.
Collapse
|
17
|
Faasse T, Shreve P. Patient and image data management in positron emission tomography-computed tomography for radiation therapy and therapy response assessment. Semin Ultrasound CT MR 2011; 31:480-9. [PMID: 21147375 DOI: 10.1053/j.sult.2010.09.001] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
This article provides an overview of the primary considerations of positron emission tomography-computed tomographic (PET-CT) workflows specifically related to patient and image data management in radiation therapy (RT) planning and therapy response assessment. PET-CT has become increasingly integral to the RT planning and therapy response assessment. There are numerous workflow challenges related to integrating PET-CT in the framework of RT planning and therapy assessment. For PET-CT scan used for RT planning, accurate patient positioning and scan registration with the simulation is critical. For therapy assessment PET-CT scans, consistency in patient preparation, scanning and image reconstruction parameters, and image analysis are critical.
Collapse
Affiliation(s)
- Todd Faasse
- Lemmen-Holton Cancer Pavilion, Spectrum Health, Grand Rapids, MI, USA.
| | | |
Collapse
|
18
|
Yoo DS, Wong TZ, Brizel DM. The Role of Adaptive and Functional Imaging Modalities in Radiation Therapy: Approach and Application from a Radiation Oncology Perspective. Semin Ultrasound CT MR 2010; 31:444-61. [DOI: 10.1053/j.sult.2010.10.002] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
|
19
|
Bettinardi V, Picchio M, Di Muzio N, Gianolli L, Gilardi MC, Messa C. Detection and compensation of organ/lesion motion using 4D-PET/CT respiratory gated acquisition techniques. Radiother Oncol 2010; 96:311-6. [PMID: 20708809 DOI: 10.1016/j.radonc.2010.07.014] [Citation(s) in RCA: 48] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/04/2010] [Revised: 07/14/2010] [Accepted: 07/15/2010] [Indexed: 12/25/2022]
Abstract
PURPOSE To describe the degradation effects produced by respiratory organ and lesion motion on PET/CT images and to define the role of respiratory gated (RG) 4D-PET/CT techniques to compensate for such effects. METHODS Based on the literature and on our own experience, technical recommendations and clinical indications for the use of RG 4D PET/CT have been outlined. RESULTS RG 4D-PET/CT techniques require a state of the art PET/CT scanner, a respiratory monitoring system and dedicated acquisition and processing protocols. Patient training is particularly important to obtain a regular breathing pattern. An adequate number of phases has to be selected to balance motion compensation and statistical noise. RG 4D PET/CT motion free images may be clinically useful for tumour tissue characterization, monitoring patient treatment and target definition in radiation therapy planning. CONCLUSIONS RG 4D PET/CT is a valuable tool to improve image quality and quantitative accuracy and to assess and measure organ and lesion motion for radiotherapy planning.
Collapse
|
20
|
Stauder MC, Miller RC. Stereotactic Body Radiation Therapy (SBRT) for Unresectable Pancreatic Carcinoma. Cancers (Basel) 2010; 2:1565-75. [PMID: 24281173 PMCID: PMC3837322 DOI: 10.3390/cancers2031565] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/28/2010] [Revised: 08/05/2010] [Accepted: 08/06/2010] [Indexed: 12/13/2022] Open
Abstract
Survival in patients with unresectable pancreatic carcinoma is poor. Studies by Mayo Clinic and the Gastrointestinal Tumor Study Group (GITSG) have established combined modality treatment with chemotherapy and radiation as the standard of care. Use of gemcitabine-based chemotherapy alone has also been shown to provide a benefit, but 5‑year overall survival still remains less than 5%. Conventional radiotherapy is traditionally delivered over a six week period and high toxicity is seen with the concomitant use of chemotherapy. In contrast, SBRT can be delivered in 3–5 days and, when used as a component of combined modality therapy with gemcitabine, disruption to the timely delivery of chemotherapy is minimal. Early single-institution reports of SBRT for unresectable pancreatic carcinoma demonstrate excellent local control with acceptable toxicity. Use of SBRT in unresectable pancreatic carcinoma warrants further investigation in order to improve the survival of patients with historically poor outcomes.
Collapse
|
21
|
Buyyounouski MK, Balter P, Lewis B, D'Ambrosio DJ, Dilling TJ, Miller RC, Schefter T, Tomé W, Harris EER, Price RA, Konski AA, Wallner PE. Stereotactic body radiotherapy for early-stage non-small-cell lung cancer: report of the ASTRO Emerging Technology Committee. Int J Radiat Oncol Biol Phys 2010; 78:3-10. [PMID: 20643514 DOI: 10.1016/j.ijrobp.2010.04.010] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2010] [Revised: 04/02/2010] [Accepted: 04/02/2010] [Indexed: 12/25/2022]
|
22
|
Interfraction and Intrafraction Setup Variability for Prone Breast Radiation Therapy. Int J Radiat Oncol Biol Phys 2010; 76:1571-7. [DOI: 10.1016/j.ijrobp.2009.07.1683] [Citation(s) in RCA: 34] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2009] [Revised: 07/20/2009] [Accepted: 07/23/2009] [Indexed: 11/20/2022]
|
23
|
Goldstein SD, Ford EC, Duhon M, McNutt T, Wong J, Herman JM. Use of respiratory-correlated four-dimensional computed tomography to determine acceptable treatment margins for locally advanced pancreatic adenocarcinoma. Int J Radiat Oncol Biol Phys 2009; 76:597-602. [PMID: 19836156 DOI: 10.1016/j.ijrobp.2009.06.009] [Citation(s) in RCA: 58] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2009] [Revised: 06/02/2009] [Accepted: 06/02/2009] [Indexed: 10/20/2022]
Abstract
PURPOSE Respiratory-induced excursions of locally advanced pancreatic adenocarcinoma could affect dose delivery. This study quantified tumor motion and evaluated standard treatment margins. METHODS AND MATERIALS Respiratory-correlated four-dimensional computed tomography images were obtained on 30 patients with locally advanced pancreatic adenocarcinoma; 15 of whom underwent repeat scanning before cone-down treatment. Treatment planning software was used to contour the gross tumor volume (GTV), bilateral kidneys, and biliary stent. Excursions were calculated according to the centroid of the contoured volumes. RESULTS The mean +/- standard deviation GTV excursion in the superoinferior (SI) direction was 0.55 +/- 0.23 cm; an expansion of 1.0 cm adequately accounted for the GTV motion in 97% of locally advanced pancreatic adenocarcinoma patients. Motion GTVs were generated and resulted in a 25% average volume increase compared with the static GTV. Of the 30 patients, 17 had biliary stents. The mean SI stent excursion was 0.84 +/- 0.32 cm, significantly greater than the GTV motion. The xiphoid process moved an average of 0.35 +/- 0.12 cm, significantly less than the GTV. The mean SI motion of the left and right kidneys was 0.65 +/- 0.27 cm and 0.77 +/- 0.30 cm, respectively. At repeat scanning, no significant changes were seen in the mean GTV size (p = .8) or excursion (p = .3). CONCLUSION These data suggest that an asymmetric expansion of 1.0, 0.7, and 0.6 cm along the respective SI, anteroposterior, and medial-lateral directions is recommended if a respiratory-correlated four-dimensional computed tomography scan is not available to evaluate the tumor motion during treatment planning. Surrogates of tumor motion, such as biliary stents or external markers, should be used with caution.
Collapse
Affiliation(s)
- Seth D Goldstein
- Department of Surgery, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University, Baltimore, MD 21231-2410, USA
| | | | | | | | | | | |
Collapse
|
24
|
Stereotactic body radiation therapy boost in locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 2009; 75:1456-61. [PMID: 19783379 DOI: 10.1016/j.ijrobp.2009.01.042] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/18/2008] [Revised: 01/06/2009] [Accepted: 01/14/2009] [Indexed: 02/07/2023]
Abstract
PURPOSE To investigate the clinical application of a stereotactic body radiation therapy (SBRT) boost in locally advanced pancreatic cancer patients with a focus on local efficacy and toxicity. METHODS AND MATERIALS We retrospectively reviewed 30 patients with locally advanced and nonmetastatic pancreatic cancer who had been treated between 2004 and 2006. Follow-up duration ranged from 4 to 41 months (median, 14.5 months). A total dose of 40 Gy was delivered in 20 fractions using a conventional three-field technique, and then a single fraction of 14, 15, 16, or 17 Gy SBRT was administered as a boost without a break. Twenty-one patients received chemotherapy. Overall and local progression-free survival were calculated and prognostic factors were evaluated. RESULTS One-year overall survival and local progression-free survival rates were 60.0% and 70.2%, respectively. One patient (3%) developed Grade 4 toxicity. Carbohydrate antigen 19-9 response was found to be an independent prognostic factor for survival. CONCLUSIONS Our findings indicate that a SBRT boost provides a safe means of increasing radiation dose. Based on the results of this study, we recommend that a well controlled Phase II study be conducted on locally advanced pancreatic cancer.
Collapse
|
25
|
Ruan D, Fessler JA, Balter JM, Keall PJ. Real-time profiling of respiratory motion: baseline drift, frequency variation and fundamental pattern change. Phys Med Biol 2009; 54:4777-92. [DOI: 10.1088/0031-9155/54/15/009] [Citation(s) in RCA: 51] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
|
26
|
Wang L, Hayes S, Paskalev K, Jin L, Buyyounouski MK, Ma CCM, Feigenberg S. Dosimetric comparison of stereotactic body radiotherapy using 4D CT and multiphase CT images for treatment planning of lung cancer: Evaluation of the impact on daily dose coverage. Radiother Oncol 2009; 91:314-24. [DOI: 10.1016/j.radonc.2008.11.018] [Citation(s) in RCA: 41] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/10/2008] [Revised: 11/12/2008] [Accepted: 11/16/2008] [Indexed: 01/23/2023]
|
27
|
Riegel AC, Ahmad M, Sun X, Pan T. Dose calculation with respiration-averaged CT processed from cine CT without a respiratory surrogate. Med Phys 2009; 35:5738-47. [PMID: 19175131 DOI: 10.1118/1.3015197] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
Abstract
Dose calculation for thoracic radiotherapy is commonly performed on a free-breathing helical CT despite artifacts caused by respiratory motion. Four-dimensional computed tomography (4D-CT) is one method to incorporate motion information into the treatment planning process. Some centers now use the respiration-averaged CT (RACT), the pixel-by-pixel average of the ten phases of 4D-CT, for dose calculation. This method, while sparing the tedious task of 4D dose calculation, still requires 4D-CT technology. The authors have recently developed a means to reconstruct RACT directly from unsorted cine CT data from which 4D-CT is formed, bypassing the need for a respiratory surrogate. Using RACT from cine CT for dose calculation may be a means to incorporate motion information into dose calculation without performing 4D-CT. The purpose of this study was to determine if RACT from cine CT can be substituted for RACT from 4D-CT for the purposes of dose calculation, and if increasing the cine duration can decrease differences between the dose distributions. Cine CT data and corresponding 4D-CT simulations for 23 patients with at least two breathing cycles per cine duration were retrieved. RACT was generated four ways: First from ten phases of 4D-CT, second, from 1 breathing cycle of images, third, from 1.5 breathing cycles of images, and fourth, from 2 breathing cycles of images. The clinical treatment plan was transferred to each RACT and dose was recalculated. Dose planes were exported at orthogonal planes through the isocenter (coronal, sagittal, and transverse orientations). The resulting dose distributions were compared using the gamma index within the planning target volume (PTV). Failure criteria were set to 2%/1 mm. A follow-up study with 50 additional lung cancer patients was performed to increase sample size. The same dose recalculation and analysis was performed. In the primary patient group, 22 of 23 patients had 100% of points within the PTV pass y criteria. The average maximum and mean y indices were very low (well below 1), indicating good agreement between dose distributions. Increasing the cine duration generally increased the dose agreement. In the follow-up study, 49 of 50 patients had 100% of points within the PTV pass the y criteria. The average maximum and mean y indices were again well below 1, indicating good agreement. Dose calculation on RACT from cine CT is negligibly different from dose calculation on RACT from 4D-CT. Differences can be decreased further by increasing the cine duration of the cine CT scan.
Collapse
Affiliation(s)
- Adam C Riegel
- Department of Imaging Physics, University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
| | | | | | | |
Collapse
|
28
|
Evaluation of four-dimensional computed tomography-based intensity-modulated and respiratory-gated radiotherapy techniques for pancreatic carcinoma. Int J Radiat Oncol Biol Phys 2008; 72:1215-20. [PMID: 18954715 DOI: 10.1016/j.ijrobp.2008.07.010] [Citation(s) in RCA: 43] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2007] [Revised: 06/09/2008] [Accepted: 07/07/2008] [Indexed: 11/21/2022]
Abstract
PURPOSE To compare conformal radiotherapy (CRT), intensity-modulated radiotherapy (IMRT), and respiration-gated radiotherapy (RGRT) planning techniques for pancreatic cancer. All target volumes were determined using four-dimensional computed tomography scans (4D CT). METHODS AND MATERIALS The pancreatic tumor and enlarged regional lymph nodes were contoured on all 10 phases of a planning 4D CT scan for 10 patients, and the planning target volumes (PTV(all phases)) were generated. Three consecutive respiratory phases for RGRT delivery in both inspiration and expiration were identified, and the corresponding PTVs (PTV(inspiration) and PTV(expiration)) and organ at risk volumes created. Treatment plans using CRT and IMRT, with and without RGRT, were created for each PTV. RESULTS Compared with the CRT plans, IMRT significantly reduced the mean volume of right kidney exposed to 20 Gy from 27.7% +/- 17.7% to 16.0% +/- 18.2% (standard deviation) (p < 0.01), but this was not achieved for the left kidney (11.1% +/- 14.2% to 5.7% +/- 6.5%; p = 0.1). The IMRT plans also reduced the mean gastric, hepatic, and small bowel doses (p < 0.01). No additional reductions in the dose to the kidneys or other organs at risk were seen when RGRT plans were combined with either CRT or IMRT, and the findings for RGRT in end-expiration and end-inspiration were similar. CONCLUSION 4D CT-based IMRT plans for pancreatic tumors significantly reduced the radiation doses to the right kidney, liver, stomach, and small bowel compared with CRT plans. The additional dosimetric benefits from RGRT appear limited in this setting.
Collapse
|
29
|
Riegel AC, Chang JY, Vedam SS, Johnson V, Chi PCM, Pan T. Cine computed tomography without respiratory surrogate in planning stereotactic radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2008; 73:433-41. [PMID: 18644683 DOI: 10.1016/j.ijrobp.2008.04.047] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/31/2007] [Revised: 04/17/2008] [Accepted: 04/21/2008] [Indexed: 12/25/2022]
Abstract
PURPOSE To determine whether cine computed tomography (CT) can serve as an alternative to four-dimensional (4D)-CT by providing tumor motion information and producing equivalent target volumes when used to contour in radiotherapy planning without a respiratory surrogate. METHODS AND MATERIALS Cine CT images from a commercial CT scanner were used to form maximum intensity projection and respiratory-averaged CT image sets. These image sets then were used together to define the targets for radiotherapy. Phantoms oscillating under irregular motion were used to assess the differences between contouring using cine CT and 4D-CT. We also retrospectively reviewed the image sets for 26 patients (27 lesions) at our institution who had undergone stereotactic radiotherapy for Stage I non-small-cell lung cancer. The patients were included if the tumor motion was >1 cm. The lesions were first contoured using maximum intensity projection and respiratory-averaged CT image sets processed from cine CT and then with 4D-CT maximum intensity projection and 10-phase image sets. The mean ratios of the volume magnitude were compared with intraobserver variation, the mean centroid shifts were calculated, and the volume overlap was assessed with the normalized Dice similarity coefficient index. RESULTS The phantom studies demonstrated that cine CT captured a greater extent of irregular tumor motion than did 4D-CT, producing a larger tumor volume. The patient studies demonstrated that the gross tumor defined using cine CT imaging was similar to, or slightly larger than, that defined using 4D-CT. CONCLUSION The results of our study have shown that cine CT is a promising alternative to 4D-CT for stereotactic radiotherapy planning.
Collapse
Affiliation(s)
- Adam C Riegel
- Department of Imaging Physics, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
| | | | | | | | | | | |
Collapse
|
30
|
Saw CB, Heron DE, Huq MS. Image-Guided Radiation Therapy: Part 3—Stereotactic Body Radiation Therapy. Med Dosim 2007; 32:69-70. [PMID: 17472884 DOI: 10.1016/j.meddos.2007.01.001] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|